Document Details
Form
Filing Date
Jan 21, 2020
Document Date
Jan 21, 2020
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Keros Therapeutics
Issuer
Keros Therapeutics, Inc.